Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479674
Status:
COMPLETED
Last Update Posted:
2015-02-18
First Post:
2007-05-25
Brief Title:
Phase II Study With Abraxane Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
Sponsor:
Organization:
Duke University